Sponsor:
Emory University
Code:
NCT05039073
Conditions
Recurrent Classic Hodgkin Lymphoma
Refractory Classic Hodgkin Lymphoma
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Brentuximab Vedotin
Hematopoietic Cell Transplantation
Nivolumab
Quality-of-Life Assessment
Questionnaire Administration
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations